Drug Resistant Diseases

Related Posts

30 Sep

The Next COVID Challenge: Building an Arsenal of Vaccines

For months, international partners have pressured the United States about intellectual property (IP) concerns and access to SARS-CoV-2 vaccines….

read more
06 Sep

How Amazon’s cloud business generates billions in profit

…One competing cloud storage provider is privately held Wasabi. Rather than offering a huge range of services like AWS,…

read more
12 Apr

7-year-old gets eSight glasses to help vision

Payton Crum, a 7-year-old first grader, got her best surprise yet Tuesday — hi-tech glasses that will help improve…

read more
25 Jan

Myomo Completes Repayment of Loan to the Massachusetts Life Sciences Center

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and the Massachusetts Life…

read more
19 Dec

Bloomsburg University Students Using 3D Tech to Pay It Forward

Three years ago, Jesse Johnson, from Northumberland, was given the gift of sight when he received a pair of…

read more
23 Nov

Thurston High musician close to goal for getting electronic glasses

Reilly Gault, a Thurston High School student and musician who is legally blind, is raising money for computerized glasses….

read more
10 Aug

CytoAgents’ Phase 1 Trial Results Show “Cytokine Release Syndrome” Drug Candidate Safe

Successful Completion of Phase 1 Clinical Trial, Close of Initial Equity Round of Funding, and Addition of Dr. Stanley…

read more
29 Jul

Generation of its Enhanced Patented Vision Assistive Technology

eSight, a cutting-edge vision enhancement platform, today announces the launch of its latest innovation, eSight 4. eSight’s wearable assistive…

read more
02 Jan

Tractor Pulls and Entrepreneurship

Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast…

read more
13 Apr

Pyramid Biosciences Announces TIME Trial™ Program Collaboration with Tempus for Patients with NTRK Fusion Solid Tumors

Pyramid Biosciences, Inc., a clinical-stage biotechnology company developing a portfolio of precision therapies targeting a range of serious diseases,…

read more